TSE:DTR Stock Latest News
Company AnnouncementsDiagnosTear Seeks FDA Guidance for TeaRx Red Eye Diagnostic Test1M ago
Company AnnouncementsDiagnosTear to Raise C$1.4 Million in Non-Brokered Private Placement2M ago
Company AnnouncementsDiagnosTear Wins French Approvals to Launch TeaRx Red Eye Clinical Study with AlyaTec8M ago
Company AnnouncementsDiagnosTear Partners with Hanson Medical to Advance TeaRx Dry-Eye Test in U.K. Market8M ago
Company AnnouncementsDiagnosTear Targets Indian Ophthalmic Market With TeaRx Distribution LOI9M ago
Company AnnouncementsDiagnosTear Reports Strong Interim Data for TeaRx Red Eye Diagnostic Platform9M agoCompany AnnouncementsDiagnosTear Technologies Confirms No Material Change Amid Market Activity10M ago
Company AnnouncementsDiagnosTear Partners with LV Prasad Eye Institute for Red Eye Diagnostic Advancement11M ago
Company AnnouncementsDiagnosTear Technologies Secures $925,000 in Private Placement11M ago
Company AnnouncementsDiagnosTear Technologies Upsizes Private Placement to $1 Million1y ago
Company AnnouncementsDiagnosTear Technologies Announces $700,000 Private Placement to Enhance Financial Position1y ago
Company AnnouncementsDiagnosTear Technologies Inc. Reports Successful AGM Outcomes1y agoCompany AnnouncementsDiagnosTear’s TeaRx™ to be Showcased at ARVO 2025 for Groundbreaking DES Study Results1y ago
Company AnnouncementsDiagnosTear Technologies Inc. Grants Over 3 Million Stock Options to Key Stakeholders1y ago
- Company AnnouncementsDiagnosTear Technologies Poised for Major Expansion in Ocular Diagnostics1y ago